Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Support us
Support us
  • Home
  • Thomas Kluiver

Thomas Kluiver

PhD student

Development of novel therapies for childhood liver cancer using liver tumor organoids

Phone 088 97 290 00
Email T.A.Kluiver-2@prinsesmaximacentrum.nl

--

Publications

7 publications in total

  • Divergent WNT signaling and drug sensitivity profiles within hepatoblastoma tumors and organoids

    • nov. 2024
    • Thomas A, Kluiver, et al
    • Nature communications

  • Targeting pediatric cancers via T-cell recognition of the monomorphic MHC class I-related protein MR1

    • mrt. 2024
    • Annelisa M, Cornel, et al
    • Journal for ImmunoTherapy of Cancer

  • Multi-dimensional profiling of hepatoblastomas and patient-derived tumor organoids uncovers tumor subpopulations with divergent WNT activation profiles and identifies pan-hepatoblastoma drug sensitivities

    • jan. 2023
    • Thomas, Kluiver, et al
    • bioRxiv

  • Long-Term Expansion of Murine Primary Hepatocyte Organoids

    • jan. 2022
    • Thomas A., Kluiver, et al

  • Long-Term Expansion of Murine Primary Hepatocyte Organoids

    • jan. 2022
    • Thomas A., Kluiver, et al
    • Methods in molecular biology (Clifton, N.J.)
View all publications